Category: Publications
Search News
Protein level predicts immunotherapy response in bowel cancer
16th January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
Read more
Discovery of lingering DNA damage could change our understanding of cancer development
15th January 2025
Dr Michael Spencer Chapman and team have uncovered forms of DNA damage in healthy cells that can persist unrepaired for years
Read more
Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease
3rd January 2025
A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.
Read more
How non-cancerous cells in pancreatic cancer may weaken the immune system’s response
12th December 2024
New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.
Read more
Cancer-killing virus treatment shows promise in brain tumour trial
8th November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
Read more
International study reveals four distinct types of oesophageal cancer
23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more